Accunovo Biotechnologies is a startup. 1 investor tracked. Status: possibledead.
Based in the United States, Accunovo Biotechnologies is a startup. Brouky records 1 investor associated with the company.
Accunovo Biotechnologies develops novel targeted PET imaging probes through a combination of biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors, focusing on prostate cancer patients who do not express prostate-specific membrane antigen (PSMA) or do not respond to PSMA-based treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.